These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 619648)

  • 1. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
    Mishell DR; Moore DE; Roy S; Brenner PF; Page MA
    Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and D-norgestrel.
    Mehta S; Joshi UM; Sankolli GM; Adatia A; Donde UM; Saxena BN
    Contraception; 1981 Mar; 23(3):241-50. PubMed ID: 7238044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
    Roy S; Stanczyk F; Mishell DR; Lumkin M; Gentzschein E
    Contraception; 1980 Jun; 21(6):595-615. PubMed ID: 6775868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
    Landgren BM; Johannisson E; Xing S; Aedo AR; Diczfalusy E
    Contraception; 1985 Dec; 32(6):581-601. PubMed ID: 3937664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
    Alvarez F; Faundes A; Johansson E; Coutinho E
    Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
    Johannisson E; Brosens I; Cornillie F; Elder M; White J; Sheppard B; Hourihan H; d'Arcangues C; Belsey EM
    Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
    Moore DE; Roy S; Stanczyk FZ; Mishell DR
    Contraception; 1978 Apr; 17(4):315-28. PubMed ID: 648154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel.
    Elkik F; Basdevant A; Jackanicz TM; Guy-Grand B; Mercier-Bodard C; Conard J; Bardin CW; Corvol P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):29-35. PubMed ID: 3086360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
    Ling WY; Wrixon W; Acorn T; Wilson E; Collins J
    Fertil Steril; 1983 Nov; 40(5):631-6. PubMed ID: 6628707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation.
    Souka AR; el Sokkary H; Kamel M; Hassan M
    Contraception; 1986 Apr; 33(4):365-71. PubMed ID: 3731776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
    Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
    Coutinho EM; Silva AR; Carreira C; Barbosa I
    Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravaginal contraception with the synthetic progestin, R2010.
    Toivonen J
    Contraception; 1979 Nov; 20(5):511-8. PubMed ID: 527342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of ovarian function by Microgynon 30 in day 1 and day 5 "starters".
    Taylor DR; Anthony FW; Dennis KJ
    Contraception; 1986 May; 33(5):463-71. PubMed ID: 3757512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.